Preview Company (Stock code) Event Presenter
Solo Oil - Kiliwani North Development Update
SOLO OIL (SOLO) Solo Oil - Kiliwani North Development Update
Neil Ritson - Chairman
Mon, 05 Oct 2015 08:05 am (UK time)
Neil Ritson - Chairman
Serabi Gold - Projects overview and update
SERABI GOLD (SRB) Serabi Gold - Projects overview and update
Michael Hodgson - Chief Executive
Mon, 05 Oct 2015 08:00 am (UK time)
Michael Hodgson - Chief Executive
ValiRx - New Japanese patent grant
VALIRX PLC (VAL) ValiRx - New Japanese patent grant
Sam Ogunsalu - Chief Commercial Officer
Fri, 02 Oct 2015 08:45 am (UK time)
Sam Ogunsalu - Chief Commercial Officer
Vertu Motors - Acquisition of SHG Holdings Ltd
VERTU MOTORS (VTU) Vertu Motors - Acquisition of SHG Holdings Ltd
Robert Forrester - Chief Executive Officer
Thu, 01 Oct 2015 04:30 pm (UK time)
Robert Forrester - Chief Executive Officer
Regenersis - Final results
REGENERSIS (RGS) Regenersis - Final results
Matthew Peacock - Executive Chairman
Thu, 01 Oct 2015 02:30 pm (UK time)
Matthew Peacock - Executive Chairman
DP Poland - CEO presents: New commissary
DP POLAND (DPP) DP Poland - CEO presents: New commissary
Peter Shaw - Chief Executive
Thu, 01 Oct 2015 02:30 pm (UK time)
Peter Shaw - Chief Executive
The Mission Marketing Group - Expansion into Asia
THE MISSION GROUP (TMMG) The Mission Marketing Group - Expansion into Asia
Poppy Robinson
Thu, 01 Oct 2015 12:05 pm (UK time)
Poppy Robinson
Bushveld Minerals Ltd - Mokopane vanadium project update
BUSHVELD MINERALS (BMN) Bushveld Minerals Ltd - Mokopane vanadium project update
Fortune Mojapelo - Chief Executive, Bushveld Minerals
Thu, 01 Oct 2015 08:30 am (UK time)
Fortune Mojapelo - Chief Executive, Bushveld Minerals
Innovation Through Collaboration
MELBOURNE MINING CLUB (5MMC) Innovation Through Collaboration
Jim Gowans - Senior Advisor to Chairman
Thu, 01 Oct 2015 07:35 am (UK time)
Jim Gowans - Senior Advisor to Chairman
Arrowhead's hepatitis B results demonstrate RNAi-based therapies are effective in clinical trials
BENITEC BIOPHARMA (BLT) Arrowhead's hepatitis B results demonstrate RNAi-based therapies are effective in clinical trials
Peter French - CEO & MD
Thu, 01 Oct 2015 04:15 am (UK time)
Peter French - CEO & MD